Buprocalm XL 150

Buprocalm XL150 contains Bupropion Hydrochloride 150 mg, formulated as a prolonged-release (extended-release) tablet. It is primarily prescribed for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid in smoking cessation therapy.

Bupropion belongs to the class of norepinephrine-dopamine reuptake inhibitors (NDRIs). Unlike many other antidepressants, it has a lower risk of sexual side effects and weight gain, making it a preferred option in certain patients.

Key Benefits:

• Effective in treating depression and mood disorders

• Helps reduce withdrawal symptoms in smoking cessation

• Improves energy, motivation, and focus

• Lower risk of weight gain and sexual dysfunction compared to SSRIs